Peanuts and Neurocognitive / Cardiovascular Health in Black Individuals
Launched by THE UNIVERSITY OF TEXAS AT ARLINGTON · Mar 12, 2024
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is looking at how eating more peanuts every day may affect brain and heart health in Black individuals. Researchers want to understand if increasing peanut consumption can help improve thinking skills and overall health, especially related to heart disease and high blood pressure.
To participate, you need to be between 18 and 50 years old and identify as either Black or White, with at least one biological parent of the same race. This study is open to both men and women. If you join, you’ll be part of a group that will monitor changes related to your health as you eat more peanuts. However, this trial is not for everyone; if you have a peanut allergy, are pregnant or breastfeeding, or have certain health conditions, you may not be eligible. If you're interested, the study is currently recruiting participants, and you can learn more about what to expect if you decide to take part.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals that self-identify as white or black and who have at least one biological parent who identifies as their own self-identified race/ethnicity will be included in this study. Both men and women will be included in this study. Individuals must be between the ages of 18-50.
- Exclusion Criteria:
- • Individuals who have donated more than 550 ml of blood within the past 8 weeks will not have blood drawn from them in this protocol. However, if they remain interested in the study, and otherwise meet the inclusion criteria, then we may still opt to proceed with data collection.
- • Individuals with peanut allergy
- • Individuals in hypertensive crisis
- • Pregnant women
- • Breast feeding
- • Allergies to spandex/lycra
About The University Of Texas At Arlington
The University of Texas at Arlington (UTA) is a leading academic institution dedicated to advancing research and innovation across various fields, including health sciences. With a strong commitment to improving public health and clinical outcomes, UTA actively sponsors clinical trials that aim to explore novel therapeutics, enhance patient care, and address pressing health challenges. The university's interdisciplinary approach fosters collaboration among researchers, healthcare professionals, and community stakeholders, ensuring that trials are conducted with rigor and integrity. UTA's state-of-the-art facilities and access to diverse patient populations enable the effective execution of clinical research, contributing to the advancement of medical knowledge and practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Arlington, Texas, United States
Patients applied
Trial Officials
Robert M Brothers, PhD
Principal Investigator
University of Texas at Arlington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported